MedTrace Logo

Speech Intelligibility in Quiet and Noise for New vs. Legacy Hearing Aids

NCT05101083 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2022-01-18

No results posted yet for this study

Summary

This clinical investigation is designed to compare audiological performance (i.e., measurements of sound quality and speech understanding) between Starkey's new receiver-in-canal device and a commercially available legacy receiver-in-canal device.

Conditions

Interventions

DEVICE

New Receiver-in-Canal Device

Successor of previous device generation

DEVICE

Legacy Receiver-in-Canal Device

Receiver-in-canal device available on the market

Sponsors & Collaborators

  • Starkey Laboratories, Inc

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-25
Primary Completion
2022-01-10
Completion
2022-01-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05101083 on ClinicalTrials.gov